Abolis Biotechnologies
tailor-made industrial solutions based on natural and modified micro-organisms
Abolis Biotechnologies has raised €35M across 1 funding round from 6 investors, most recently a round in Sep 2024. Based in Evry, France; active in Healthtech. Data as of 28 Oct 2026.
Evry, Francewww.abolis.fr ↗
Total raised
€35M
€35,000,000
Funding rounds
1
Investors
6
distinct backers
Active since
2024-09
latest 2024-09
Funding by year
EUR raised per yearAbolis Biotechnologies — funding by year — interactive chart.
Data table
| Abolis Biotechnologies — funding by year | |
|---|---|
| 2024 | €35M |
Signals
High confidenceRaise-next likelihood22
base rate 30% for Other
- ▼ In typical raise window
- ▼ Low backer re-investment
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-09-12 | Other | €35M | BOLD,Clay Capital,DeepTech & Climate Fonds,Evonik Venture Capital GmbH,ICOS Capital Management,LIBERSET | View deal → |
Investors
6Related news
Similar companies
same sector or country- Mistral AI€6.5BFrance · AI
- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData